Parkinson's disease and low frequency alleles found together throughout LRRK2
- PMID: 19489756
- PMCID: PMC5217459
- DOI: 10.1111/j.1469-1809.2009.00524.x
Parkinson's disease and low frequency alleles found together throughout LRRK2
Abstract
Mutations within LRRK2, most notably p.G2019S, cause Parkinson's disease (PD) in rare monogenic families, and sporadic occurrences in diverse populations. We investigated variation throughout LRRK2 (84 SNPs; genotype or diplotype found for 49 LD blocks) for 275 cases (European ancestry, onset at age 60 or older) and 275 neurologically healthy control subjects (NINDS Neurogenetics Repository). Three grade-of-membership groups, i.e. genetic risk sets, were identified that exactly matched many subjects (cases: 46, 4, 137; controls: 0, 178, 0), and distinguished 94% of the subjects (i.e. >50% likeness to one set). Set I, affected, carried certain low frequency alleles located in multiple functional domains. Set II was unaffected. Set III, also affected, resembled set II except for slightly elevated frequencies of minor alleles not defining set I. We conclude that certain low frequency alleles distributed throughout LRRK2 are a genetic background to a third of cases, defining a distinct subset.
Figures
Similar articles
-
LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease.Parkinsonism Relat Disord. 2009 Mar;15(3):175-80. doi: 10.1016/j.parkreldis.2008.05.004. Epub 2008 Aug 26. Parkinsonism Relat Disord. 2009. PMID: 18752982 Free PMC article.
-
Genetic causes of Parkinson's disease in the Maltese: a study of selected mutations in LRRK2, MTHFR, QDPR and SPR.BMC Med Genet. 2016 Sep 9;17(1):65. doi: 10.1186/s12881-016-0327-x. BMC Med Genet. 2016. PMID: 27613114 Free PMC article.
-
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.Neurology. 2006 Nov 28;67(10):1786-91. doi: 10.1212/01.wnl.0000244345.49809.36. Epub 2006 Oct 18. Neurology. 2006. PMID: 17050822
-
LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.J Neural Transm (Vienna). 2010 Jul;117(7):847-53. doi: 10.1007/s00702-010-0423-6. Epub 2010 Jun 11. J Neural Transm (Vienna). 2010. PMID: 20544233
-
Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease.Parkinsonism Relat Disord. 2011 Aug;17(7):501-8. doi: 10.1016/j.parkreldis.2010.11.008. Parkinsonism Relat Disord. 2011. PMID: 21641266 Review.
Cited by
-
LRRK2 at the Crossroad of Aging and Parkinson's Disease.Genes (Basel). 2021 Mar 29;12(4):505. doi: 10.3390/genes12040505. Genes (Basel). 2021. PMID: 33805527 Free PMC article. Review.
-
Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.PLoS One. 2012;7(4):e34693. doi: 10.1371/journal.pone.0034693. Epub 2012 Apr 9. PLoS One. 2012. PMID: 22496842 Free PMC article.
-
Calabria as a Genetic Isolate: A Model for the Study of Neurodegenerative Diseases.Biomedicines. 2022 Sep 15;10(9):2288. doi: 10.3390/biomedicines10092288. Biomedicines. 2022. PMID: 36140389 Free PMC article. Review.
-
Genetic variability at the PARK16 locus.Eur J Hum Genet. 2010 Dec;18(12):1356-9. doi: 10.1038/ejhg.2010.125. Epub 2010 Aug 4. Eur J Hum Genet. 2010. PMID: 20683486 Free PMC article.
-
An evolutionary framework for association testing in resequencing studies.PLoS Genet. 2010 Nov 11;6(11):e1001202. doi: 10.1371/journal.pgen.1001202. PLoS Genet. 2010. PMID: 21085648 Free PMC article.
References
-
- Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Changing epidemiology of Parkinson’s disease in southwestern Finland. Neurology. 1999;52:302–308. - PubMed
-
- Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW, International LRRK2 Consortium Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol. 2008 Jul;7(7):583–90. Epub 2008 Jun 6. - PMC - PubMed
-
- Marín I, van Egmond WN, van Haastert PJ. The Roco protein family: a functional perspective. FASEB J. 2008 Sep;22(9):3103–10. Epub 2008 Jun 3. - PubMed
-
- Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A. Genome-wide genotyping in Parkinson’s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2006b;5:911–916. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials